The mTOR pathway is the foremost multifunctional orchestrator of NAFLD/NASH progression and associated HCC development responding to metabolic syndrome, diabetes, hyperinsulinemia, insulin resistance, and dyslipidemia. This evidence concerns the gene MTOR and Hyperinsulinemia.